Clinical Trials Directory

Trials / Completed

CompletedNCT01557803

Prediction and Pathogenesis of the Immune Reconstitution Inflammatory Syndrome

Prediction and Pathogenesis of the Immune Reconstitution Inflammatory Syndrome in Lambaréné, Gabon

Status
Completed
Phase
Study type
Observational
Enrollment
107 (actual)
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of this project is to determine clinical and biological predictors of Immune Reconstitution Inflammatory Syndrome (IRIS) occurrence in HIV infected patients who are started on antiretroviral therapy (ART), and to obtain more insight into the pathogenesis of this syndrome. The investigators will prospectively study HIV infected patients in Sub Saharan Africa who will be initiated on ART and are at risk to develop IRIS in all its different appearances. In these patients, the investigators will assess the value of clinical features and plasma biomarkers to predict IRIS, and the investigators will obtain insight into which inflammatory pathways become activated during IRIS. This project will provide novel knowledge about this clinically highly relevant healthcare problem in a resource poor setting, namely in Lambaréné, Gabon, in the Central African rainforest belt. In Gabon little research has been done in the field of HIV. The epidemiological pattern of IRIS in Gabon will be described. Promising putative plasma biomarkers will be validated for their use in daily practice.

Conditions

Timeline

Start date
2012-01-01
Primary completion
2014-02-01
Completion
2015-01-01
First posted
2012-03-20
Last updated
2015-01-14

Locations

1 site across 1 country: Gabon

Source: ClinicalTrials.gov record NCT01557803. Inclusion in this directory is not an endorsement.